Back
Protagonist Therapeutics Vs. Nike Industry Stock Comparison
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
34.61
Seasonality Move:
2.56%
Sell
17
NKE
Nike
Last Price:
76.06
Seasonality Move:
6.25%
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $34.59. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $76.04. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $34.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
NKE Stock Price Chart
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.95 | Buy |
Relative Strength Index (14 RSI): | 61.87 | Buy |
Chaikin Money Flow: | -8110508 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.98 - 34.42) | Buy |
Bollinger Bands (100): | (26.65 - 31.91) | Buy |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.2 | Sell |
Relative Strength Index (14 RSI): | 21.68 | Sell |
Chaikin Money Flow: | -4026097 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.28 - 98.68) | Sell |
Bollinger Bands (100): | (89.69 - 101.25) | Sell |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.01 | Buy |
20-day SMA: | 33.08 | Buy |
50-day SMA: | 30.12 | Buy |
200-day SMA: | 24.34 | Buy |
8-day EMA: | 33.53 | Buy |
20-day EMA: | 32.64 | Buy |
50-day EMA: | 30.94 | Buy |
200-day EMA: | 26.19 | Buy |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.2 | Sell |
20-day SMA: | 92.27 | Sell |
50-day SMA: | 92.61 | Sell |
200-day SMA: | 100.01 | Sell |
8-day EMA: | 85 | Sell |
20-day EMA: | 89.87 | Sell |
50-day EMA: | 92.49 | Sell |
200-day EMA: | 99.26 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.
Protagonist Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |